Annexin Pharmaceuticals AB (publ) (STO: ANNX)
Sweden
· Delayed Price · Currency is SEK 0.483
+0.001 (0.21%)
Dec 3, 2024, 1:34 PM CET
ANNX Balance Sheet
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Cash & Equivalents | 25.64 | 21.42 | 31.11 | 49.48 | 18.13 | 4.26 | Upgrade
|
| Cash & Short-Term Investments | 25.64 | 21.42 | 31.11 | 49.48 | 18.13 | 4.26 | Upgrade
|
| Cash Growth | 126.80% | -31.17% | -37.12% | 172.88% | 325.33% | -85.89% | Upgrade
|
| Other Receivables | 0.81 | 2.63 | 1.86 | 1.02 | 0.28 | 0.27 | Upgrade
|
| Receivables | 0.81 | 2.63 | 1.86 | 1.02 | 0.28 | 0.27 | Upgrade
|
| Inventory | - | - | - | - | 4.28 | 8.56 | Upgrade
|
| Prepaid Expenses | 0.44 | 0.87 | 0.67 | 0.22 | 0.2 | 0.59 | Upgrade
|
| Total Current Assets | 26.89 | 24.92 | 33.65 | 50.72 | 22.9 | 13.68 | Upgrade
|
| Property, Plant & Equipment | 1.1 | 1.17 | 1.26 | 1.35 | 1.44 | 1.53 | Upgrade
|
| Long-Term Investments | 0.31 | 0.31 | 0.41 | 0.15 | 0.15 | 0.05 | Upgrade
|
| Other Intangible Assets | 0.29 | 0.37 | 0.47 | 0.58 | 0.68 | 0.78 | Upgrade
|
| Other Long-Term Assets | - | - | 0.89 | - | - | - | Upgrade
|
| Total Assets | 28.6 | 26.76 | 36.68 | 52.79 | 25.16 | 16.04 | Upgrade
|
| Accounts Payable | 1.62 | 4.33 | 3.33 | 3.51 | 2.9 | 2.41 | Upgrade
|
| Accrued Expenses | 1.56 | 3.3 | 2.43 | 1.7 | 1.42 | 1.53 | Upgrade
|
| Current Portion of Long-Term Debt | - | - | - | - | - | 0.23 | Upgrade
|
| Other Current Liabilities | 0.33 | 0.32 | 0.77 | 0.84 | 0.2 | 0.39 | Upgrade
|
| Total Current Liabilities | 3.51 | 7.95 | 6.53 | 6.06 | 4.52 | 4.55 | Upgrade
|
| Total Liabilities | 3.51 | 7.95 | 6.53 | 6.06 | 4.52 | 4.55 | Upgrade
|
| Common Stock | 8.82 | 5.74 | 2.56 | 27.45 | 21.22 | 17.68 | Upgrade
|
| Additional Paid-In Capital | 340.38 | 299.29 | 269.63 | 220.91 | 148.91 | 99.05 | Upgrade
|
| Retained Earnings | -324.11 | -286.21 | -242.16 | -201.63 | -149.49 | -105.25 | Upgrade
|
| Comprehensive Income & Other | -0 | - | 0.12 | - | - | 0 | Upgrade
|
| Shareholders' Equity | 25.09 | 18.81 | 30.15 | 46.73 | 20.64 | 11.49 | Upgrade
|
| Total Liabilities & Equity | 28.6 | 26.76 | 36.68 | 52.79 | 25.16 | 16.04 | Upgrade
|
| Total Debt | - | - | - | - | - | 0.23 | Upgrade
|
| Net Cash (Debt) | 25.64 | 21.42 | 31.11 | 49.48 | 18.13 | 4.04 | Upgrade
|
| Net Cash Growth | 1864.75% | -31.17% | -37.12% | 172.88% | 349.26% | -86.43% | Upgrade
|
| Net Cash Per Share | 0.07 | 0.13 | 0.21 | 0.60 | 0.29 | 0.23 | Upgrade
|
| Filing Date Shares Outstanding | 532.98 | 346.58 | 154.5 | 137.24 | 70.73 | 17.68 | Upgrade
|
| Total Common Shares Outstanding | 532.98 | 346.58 | 154.5 | 137.24 | 70.73 | 17.68 | Upgrade
|
| Working Capital | 23.38 | 16.97 | 27.12 | 44.66 | 18.38 | 9.13 | Upgrade
|
| Book Value Per Share | 0.05 | 0.05 | 0.20 | 0.34 | 0.29 | 0.65 | Upgrade
|
| Tangible Book Value | 24.79 | 18.44 | 29.68 | 46.15 | 19.96 | 10.71 | Upgrade
|
| Tangible Book Value Per Share | 0.05 | 0.05 | 0.19 | 0.34 | 0.28 | 0.61 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.